nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—CYP11B1—hypertension	0.133	0.361	CbGaD
Etomidate—CYP11B2—hypertension	0.125	0.34	CbGaD
Etomidate—Fenoprofen—Bumetanide—hypertension	0.107	0.668	CrCrCtD
Etomidate—CYP11B2—Eplerenone—hypertension	0.0782	0.276	CbGbCtD
Etomidate—ADRA2B—hypertension	0.0772	0.209	CbGaD
Etomidate—CYP11B2—Spironolactone—hypertension	0.0614	0.217	CbGbCtD
Etomidate—Fenoprofen—Labetalol—hypertension	0.0529	0.332	CrCrCtD
Etomidate—CYP11B1—Spironolactone—hypertension	0.0399	0.141	CbGbCtD
Etomidate—CYP19A1—hypertension	0.0331	0.0898	CbGaD
Etomidate—ADRA2B—Guanabenz—hypertension	0.0242	0.0854	CbGbCtD
Etomidate—ADRA2B—Guanfacine—hypertension	0.0225	0.0794	CbGbCtD
Etomidate—ADRA2B—Fenoldopam—hypertension	0.0191	0.0675	CbGbCtD
Etomidate—ADRA2B—Prazosin—hypertension	0.0145	0.0512	CbGbCtD
Etomidate—ADRA2B—Carvedilol—hypertension	0.0125	0.0442	CbGbCtD
Etomidate—CYP11B2—zona fasciculata of adrenal gland—hypertension	0.0116	0.212	CbGeAlD
Etomidate—CYP11B1—zona fasciculata of adrenal gland—hypertension	0.0116	0.212	CbGeAlD
Etomidate—ADRA2B—Clonidine—hypertension	0.011	0.0388	CbGbCtD
Etomidate—CYP11B2—zona glomerulosa of adrenal gland—hypertension	0.0101	0.185	CbGeAlD
Etomidate—CYP11B1—zona glomerulosa of adrenal gland—hypertension	0.0101	0.185	CbGeAlD
Etomidate—SLC2A1—endothelium—hypertension	0.00127	0.0233	CbGeAlD
Etomidate—SLC2A1—blood vessel—hypertension	0.00118	0.0215	CbGeAlD
Etomidate—SLC2A1—brainstem—hypertension	0.000643	0.0118	CbGeAlD
Etomidate—SLC2A1—heart—hypertension	0.000556	0.0102	CbGeAlD
Etomidate—SLC2A1—decidua—hypertension	0.00054	0.00988	CbGeAlD
Etomidate—SLC2A1—cardiovascular system—hypertension	0.000524	0.00959	CbGeAlD
Etomidate—SLC2A1—kidney—hypertension	0.000513	0.00938	CbGeAlD
Etomidate—CYP11B2—adrenal cortex—hypertension	0.000492	0.009	CbGeAlD
Etomidate—CYP11B1—adrenal cortex—hypertension	0.000492	0.009	CbGeAlD
Etomidate—CYP11B2—heart—hypertension	0.000476	0.0087	CbGeAlD
Etomidate—CYP11B2—cardiovascular system—hypertension	0.000449	0.00821	CbGeAlD
Etomidate—SLC2A1—adrenal gland—hypertension	0.000415	0.00759	CbGeAlD
Etomidate—Diethylpropion—SLC6A2—hypertension	0.000379	0.16	CrCbGaD
Etomidate—SLC2A1—endocrine gland—hypertension	0.00036	0.00658	CbGeAlD
Etomidate—CYP11B1—adrenal gland—hypertension	0.000355	0.0065	CbGeAlD
Etomidate—CYP11B2—adrenal gland—hypertension	0.000355	0.0065	CbGeAlD
Etomidate—SLC2A1—central nervous system—hypertension	0.000324	0.00593	CbGeAlD
Etomidate—CYP11B2—endocrine gland—hypertension	0.000308	0.00563	CbGeAlD
Etomidate—CYP11B1—endocrine gland—hypertension	0.000308	0.00563	CbGeAlD
Etomidate—GABRB2—brainstem—hypertension	0.000251	0.00458	CbGeAlD
Etomidate—Bradycardia—Labetalol—hypertension	0.00023	0.00475	CcSEcCtD
Etomidate—Arrhythmia—Quinapril—hypertension	0.000229	0.00473	CcSEcCtD
Etomidate—Hypotension—Fenoldopam—hypertension	0.000228	0.0047	CcSEcCtD
Etomidate—Arrhythmia—Benazepril—hypertension	0.000226	0.00465	CcSEcCtD
Etomidate—Ephedrine—SLC6A2—hypertension	0.000225	0.0947	CrCbGaD
Etomidate—Bradycardia—Eprosartan—hypertension	0.000223	0.0046	CcSEcCtD
Etomidate—GABRA1—brainstem—hypertension	0.000221	0.00405	CbGeAlD
Etomidate—Arrhythmia—Felodipine—hypertension	0.000217	0.00448	CcSEcCtD
Etomidate—Bradycardia—Amlodipine—hypertension	0.000217	0.00447	CcSEcCtD
Etomidate—Respiratory failure—Timolol—hypertension	0.000216	0.00446	CcSEcCtD
Etomidate—Pain—Ethacrynic acid—hypertension	0.000216	0.00445	CcSEcCtD
Etomidate—Pain—Reserpine—hypertension	0.000216	0.00445	CcSEcCtD
Etomidate—Hypertension—Bepridil—hypertension	0.000213	0.00439	CcSEcCtD
Etomidate—Hypotension—Torasemide—hypertension	0.000209	0.00432	CcSEcCtD
Etomidate—Arrhythmia—Terazosin—hypertension	0.000209	0.00431	CcSEcCtD
Etomidate—Tachycardia—Prazosin—hypertension	0.000208	0.00428	CcSEcCtD
Etomidate—Hypertension—Candesartan—hypertension	0.000205	0.00423	CcSEcCtD
Etomidate—Hypotension—Chlorothiazide—hypertension	0.000204	0.0042	CcSEcCtD
Etomidate—Bradycardia—Metoprolol—hypertension	0.000204	0.0042	CcSEcCtD
Etomidate—Hypotension—Bumetanide—hypertension	0.000199	0.0041	CcSEcCtD
Etomidate—Vomiting—Mecamylamine—hypertension	0.000193	0.00399	CcSEcCtD
Etomidate—Diethylpropion—SLC6A3—hypertension	0.000193	0.0813	CrCbGaD
Etomidate—Pain—Torasemide—hypertension	0.000192	0.00395	CcSEcCtD
Etomidate—Vomiting—Triamterene—hypertension	0.000191	0.00393	CcSEcCtD
Etomidate—Arrhythmia—Amlodipine—hypertension	0.00019	0.00392	CcSEcCtD
Etomidate—Tachycardia—Candesartan—hypertension	0.000189	0.00391	CcSEcCtD
Etomidate—Hypertension—Nadolol—hypertension	0.000189	0.0039	CcSEcCtD
Etomidate—Bradycardia—Propranolol—hypertension	0.000187	0.00386	CcSEcCtD
Etomidate—Convulsion—Guanfacine—hypertension	0.000186	0.00384	CcSEcCtD
Etomidate—Hypertension—Guanfacine—hypertension	0.000186	0.00383	CcSEcCtD
Etomidate—Hypertension—Nicardipine—hypertension	0.000185	0.00381	CcSEcCtD
Etomidate—Tachycardia—Hydralazine—hypertension	0.000183	0.00378	CcSEcCtD
Etomidate—Hypertension—Metolazone—hypertension	0.000183	0.00377	CcSEcCtD
Etomidate—Pain—Prazosin—hypertension	0.000182	0.00375	CcSEcCtD
Etomidate—Hypotension—Candesartan—hypertension	0.000181	0.00374	CcSEcCtD
Etomidate—Tachycardia—Pindolol—hypertension	0.000181	0.00373	CcSEcCtD
Etomidate—Bradycardia—Diltiazem—hypertension	0.000181	0.00373	CcSEcCtD
Etomidate—Bradycardia—Carvedilol—hypertension	0.000179	0.0037	CcSEcCtD
Etomidate—Convulsion—Esmolol—hypertension	0.000179	0.00369	CcSEcCtD
Etomidate—Arrhythmia—Metoprolol—hypertension	0.000179	0.00368	CcSEcCtD
Etomidate—Tachycardia—Quinapril—hypertension	0.000178	0.00367	CcSEcCtD
Etomidate—Bradycardia—Doxazosin—hypertension	0.000177	0.00365	CcSEcCtD
Etomidate—Convulsion—Terazosin—hypertension	0.000177	0.00364	CcSEcCtD
Etomidate—Vomiting—Bendroflumethiazide—hypertension	0.000176	0.00364	CcSEcCtD
Etomidate—Pethidine—SLC6A2—hypertension	0.000176	0.0743	CrCbGaD
Etomidate—Hypotension—Hydralazine—hypertension	0.000176	0.00362	CcSEcCtD
Etomidate—Bradycardia—Fosinopril—hypertension	0.000175	0.00361	CcSEcCtD
Etomidate—GABRG2—medulla oblongata—hypertension	0.000175	0.0032	CbGeAlD
Etomidate—GABRB2—medulla oblongata—hypertension	0.000175	0.0032	CbGeAlD
Etomidate—Hypotension—Pindolol—hypertension	0.000173	0.00357	CcSEcCtD
Etomidate—Bradycardia—Nifedipine—hypertension	0.000173	0.00356	CcSEcCtD
Etomidate—Bradycardia—Verapamil—hypertension	0.000172	0.00355	CcSEcCtD
Etomidate—Pain—Bepridil—hypertension	0.000172	0.00355	CcSEcCtD
Etomidate—Tachycardia—Isradipine—hypertension	0.000172	0.00354	CcSEcCtD
Etomidate—Tachycardia—Guanfacine—hypertension	0.000171	0.00353	CcSEcCtD
Etomidate—Tachycardia—Nicardipine—hypertension	0.000171	0.00352	CcSEcCtD
Etomidate—Pseudoephedrine—SLC6A2—hypertension	0.00017	0.0718	CrCbGaD
Etomidate—Pain—Penbutolol—hypertension	0.00017	0.00351	CcSEcCtD
Etomidate—Hypertension—Labetalol—hypertension	0.00017	0.00351	CcSEcCtD
Etomidate—Tachycardia—Felodipine—hypertension	0.000169	0.00348	CcSEcCtD
Etomidate—Hypotension—Benazepril—hypertension	0.000168	0.00346	CcSEcCtD
Etomidate—Hypotension—Nadolol—hypertension	0.000167	0.00344	CcSEcCtD
Etomidate—Vomiting—Hydroflumethiazide—hypertension	0.000165	0.00341	CcSEcCtD
Etomidate—Hypotension—Isradipine—hypertension	0.000164	0.00339	CcSEcCtD
Etomidate—Hypotension—Guanfacine—hypertension	0.000164	0.00338	CcSEcCtD
Etomidate—Hypotension—Nicardipine—hypertension	0.000163	0.00337	CcSEcCtD
Etomidate—Tachycardia—Terazosin—hypertension	0.000162	0.00335	CcSEcCtD
Etomidate—Pain—Amiloride—hypertension	0.000161	0.00331	CcSEcCtD
Etomidate—Vomiting—Ethacrynic acid—hypertension	0.000161	0.00331	CcSEcCtD
Etomidate—Vomiting—Reserpine—hypertension	0.000161	0.00331	CcSEcCtD
Etomidate—Arrhythmia—Diltiazem—hypertension	0.000159	0.00327	CcSEcCtD
Etomidate—Arrhythmia—Indapamide—hypertension	0.000159	0.00327	CcSEcCtD
Etomidate—Pain—Pindolol—hypertension	0.000159	0.00327	CcSEcCtD
Etomidate—Ephedrine—ADRA1A—hypertension	0.000158	0.0667	CrCbGaD
Etomidate—Hypotension—Esmolol—hypertension	0.000158	0.00325	CcSEcCtD
Etomidate—Arrhythmia—Doxazosin—hypertension	0.000156	0.00321	CcSEcCtD
Etomidate—Hypotension—Terazosin—hypertension	0.000155	0.00321	CcSEcCtD
Etomidate—Vomiting—Fenoldopam—hypertension	0.000155	0.00319	CcSEcCtD
Etomidate—GABRA1—medulla oblongata—hypertension	0.000154	0.00282	CbGeAlD
Etomidate—Arrhythmia—Fosinopril—hypertension	0.000154	0.00317	CcSEcCtD
Etomidate—Pain—Nadolol—hypertension	0.000153	0.00315	CcSEcCtD
Etomidate—Bradycardia—Clonidine—hypertension	0.000153	0.00315	CcSEcCtD
Etomidate—Tachycardia—Eprosartan—hypertension	0.000152	0.00313	CcSEcCtD
Etomidate—Arrhythmia—Nifedipine—hypertension	0.000152	0.00313	CcSEcCtD
Etomidate—Hypotension—Acebutolol—hypertension	0.000152	0.00313	CcSEcCtD
Etomidate—Vomiting—Nebivolol—hypertension	0.000151	0.00312	CcSEcCtD
Etomidate—Hypertension—Guanabenz—hypertension	0.00015	0.0031	CcSEcCtD
Etomidate—Hypertension—Metoprolol—hypertension	0.00015	0.0031	CcSEcCtD
Etomidate—Hypotension—Labetalol—hypertension	0.00015	0.0031	CcSEcCtD
Etomidate—Pain—Nicardipine—hypertension	0.000149	0.00308	CcSEcCtD
Etomidate—Bradycardia—Trandolapril—hypertension	0.000149	0.00307	CcSEcCtD
Etomidate—Bradycardia—Enalapril—hypertension	0.000148	0.00306	CcSEcCtD
Etomidate—Pain—Metolazone—hypertension	0.000148	0.00305	CcSEcCtD
Etomidate—Tachycardia—Amlodipine—hypertension	0.000148	0.00304	CcSEcCtD
Etomidate—Tachycardia—Nisoldipine—hypertension	0.000148	0.00304	CcSEcCtD
Etomidate—Bradycardia—Telmisartan—hypertension	0.000146	0.00302	CcSEcCtD
Etomidate—Hypotension—Eprosartan—hypertension	0.000146	0.003	CcSEcCtD
Etomidate—Pain—Esmolol—hypertension	0.000144	0.00297	CcSEcCtD
Etomidate—Vomiting—Torasemide—hypertension	0.000142	0.00294	CcSEcCtD
Etomidate—Pain—Terazosin—hypertension	0.000142	0.00293	CcSEcCtD
Etomidate—Hypotension—Nisoldipine—hypertension	0.000141	0.00291	CcSEcCtD
Etomidate—Arrhythmia—Olmesartan—hypertension	0.00014	0.00288	CcSEcCtD
Etomidate—Pain—Acebutolol—hypertension	0.000139	0.00286	CcSEcCtD
Etomidate—Vomiting—Chlorothiazide—hypertension	0.000139	0.00286	CcSEcCtD
Etomidate—Tachycardia—Guanabenz—hypertension	0.000139	0.00286	CcSEcCtD
Etomidate—Tachycardia—Metoprolol—hypertension	0.000139	0.00286	CcSEcCtD
Etomidate—Convulsion—Propranolol—hypertension	0.000139	0.00286	CcSEcCtD
Etomidate—Bradycardia—Perindopril—hypertension	0.000138	0.00285	CcSEcCtD
Etomidate—Bradycardia—Irbesartan—hypertension	0.000138	0.00284	CcSEcCtD
Etomidate—Pain—Labetalol—hypertension	0.000137	0.00283	CcSEcCtD
Etomidate—Bradycardia—Hydrochlorothiazide—hypertension	0.000137	0.00281	CcSEcCtD
Etomidate—Vomiting—Chlorthalidone—hypertension	0.000136	0.00281	CcSEcCtD
Etomidate—Vomiting—Bumetanide—hypertension	0.000135	0.00279	CcSEcCtD
Etomidate—Vomiting—Prazosin—hypertension	0.000135	0.00279	CcSEcCtD
Etomidate—Arrhythmia—Clonidine—hypertension	0.000134	0.00276	CcSEcCtD
Etomidate—Pain—Eprosartan—hypertension	0.000133	0.00275	CcSEcCtD
Etomidate—Bradycardia—Betaxolol—hypertension	0.000133	0.00274	CcSEcCtD
Etomidate—Convulsion—Carvedilol—hypertension	0.000133	0.00274	CcSEcCtD
Etomidate—Hypotension—Guanabenz—hypertension	0.000133	0.00274	CcSEcCtD
Etomidate—Hypotension—Metoprolol—hypertension	0.000133	0.00274	CcSEcCtD
Etomidate—Hypertension—Carvedilol—hypertension	0.000132	0.00273	CcSEcCtD
Etomidate—Convulsion—Doxazosin—hypertension	0.000131	0.00271	CcSEcCtD
Etomidate—CYP19A1—adrenal gland—hypertension	0.000131	0.0024	CbGeAlD
Etomidate—Hypertension—Doxazosin—hypertension	0.000131	0.0027	CcSEcCtD
Etomidate—Arrhythmia—Trandolapril—hypertension	0.000131	0.00269	CcSEcCtD
Etomidate—Arrhythmia—Enalapril—hypertension	0.00013	0.00268	CcSEcCtD
Etomidate—Pain—Amlodipine—hypertension	0.000129	0.00267	CcSEcCtD
Etomidate—Hypertension—Fosinopril—hypertension	0.000129	0.00267	CcSEcCtD
Etomidate—Arrhythmia—Telmisartan—hypertension	0.000128	0.00265	CcSEcCtD
Etomidate—Convulsion—Verapamil—hypertension	0.000127	0.00263	CcSEcCtD
Etomidate—Hypertension—Verapamil—hypertension	0.000127	0.00262	CcSEcCtD
Etomidate—GABRG2—central nervous system—hypertension	0.000126	0.00231	CbGeAlD
Etomidate—GABRB2—central nervous system—hypertension	0.000126	0.00231	CbGeAlD
Etomidate—Vomiting—Candesartan—hypertension	0.000123	0.00254	CcSEcCtD
Etomidate—Tachycardia—Indapamide—hypertension	0.000123	0.00254	CcSEcCtD
Etomidate—Tachycardia—Diltiazem—hypertension	0.000123	0.00254	CcSEcCtD
Etomidate—Tachycardia—Carvedilol—hypertension	0.000122	0.00252	CcSEcCtD
Etomidate—Vomiting—Methyldopa—hypertension	0.000122	0.00251	CcSEcCtD
Etomidate—Pain—Metoprolol—hypertension	0.000122	0.00251	CcSEcCtD
Etomidate—Pain—Guanabenz—hypertension	0.000122	0.00251	CcSEcCtD
Etomidate—Arrhythmia—Perindopril—hypertension	0.000121	0.0025	CcSEcCtD
Etomidate—Arrhythmia—Irbesartan—hypertension	0.000121	0.00249	CcSEcCtD
Etomidate—Tachycardia—Doxazosin—hypertension	0.000121	0.00249	CcSEcCtD
Etomidate—Pseudoephedrine—ADRA1A—hypertension	0.00012	0.0506	CrCbGaD
Etomidate—Arrhythmia—Hydrochlorothiazide—hypertension	0.00012	0.00247	CcSEcCtD
Etomidate—Vomiting—Amiloride—hypertension	0.000119	0.00246	CcSEcCtD
Etomidate—Vomiting—Hydralazine—hypertension	0.000119	0.00246	CcSEcCtD
Etomidate—Tachycardia—Fosinopril—hypertension	0.000119	0.00246	CcSEcCtD
Etomidate—Hypotension—Indapamide—hypertension	0.000118	0.00243	CcSEcCtD
Etomidate—Hypotension—Diltiazem—hypertension	0.000118	0.00243	CcSEcCtD
Etomidate—Vomiting—Pindolol—hypertension	0.000118	0.00243	CcSEcCtD
Etomidate—Arrhythmia—Furosemide—hypertension	0.000118	0.00243	CcSEcCtD
Etomidate—Tachycardia—Nifedipine—hypertension	0.000118	0.00243	CcSEcCtD
Etomidate—Tachycardia—Verapamil—hypertension	0.000117	0.00242	CcSEcCtD
Etomidate—Hypotension—Carvedilol—hypertension	0.000117	0.00241	CcSEcCtD
Etomidate—Arrhythmia—Betaxolol—hypertension	0.000117	0.0024	CcSEcCtD
Etomidate—Vomiting—Quinapril—hypertension	0.000116	0.00239	CcSEcCtD
Etomidate—Hypotension—Doxazosin—hypertension	0.000116	0.00238	CcSEcCtD
Etomidate—Hypotension—Fosinopril—hypertension	0.000114	0.00235	CcSEcCtD
Etomidate—Vomiting—Benazepril—hypertension	0.000114	0.00235	CcSEcCtD
Etomidate—CYP19A1—endocrine gland—hypertension	0.000114	0.00208	CbGeAlD
Etomidate—Vomiting—Nadolol—hypertension	0.000114	0.00234	CcSEcCtD
Etomidate—Arrhythmia—Losartan—hypertension	0.000114	0.00234	CcSEcCtD
Etomidate—Hypotension—Eplerenone—hypertension	0.000114	0.00234	CcSEcCtD
Etomidate—Hypotension—Nifedipine—hypertension	0.000113	0.00232	CcSEcCtD
Etomidate—Hypotension—Verapamil—hypertension	0.000112	0.00231	CcSEcCtD
Etomidate—Vomiting—Isradipine—hypertension	0.000112	0.00231	CcSEcCtD
Etomidate—GABRA1—central nervous system—hypertension	0.000112	0.00204	CbGeAlD
Etomidate—Pain—Propranolol—hypertension	0.000112	0.0023	CcSEcCtD
Etomidate—Vomiting—Guanfacine—hypertension	0.000112	0.0023	CcSEcCtD
Etomidate—Vomiting—Nicardipine—hypertension	0.000111	0.00229	CcSEcCtD
Etomidate—Vomiting—Metolazone—hypertension	0.00011	0.00227	CcSEcCtD
Etomidate—Vomiting—Felodipine—hypertension	0.00011	0.00227	CcSEcCtD
Etomidate—Vomiting—Spironolactone—hypertension	0.000109	0.00226	CcSEcCtD
Etomidate—Bradycardia—Timolol—hypertension	0.000109	0.00224	CcSEcCtD
Etomidate—Tachycardia—Olmesartan—hypertension	0.000109	0.00224	CcSEcCtD
Etomidate—Pain—Diltiazem—hypertension	0.000108	0.00223	CcSEcCtD
Etomidate—Pain—Indapamide—hypertension	0.000108	0.00223	CcSEcCtD
Etomidate—Hypertension—Telmisartan—hypertension	0.000108	0.00223	CcSEcCtD
Etomidate—Vomiting—Esmolol—hypertension	0.000107	0.00221	CcSEcCtD
Etomidate—Pain—Carvedilol—hypertension	0.000107	0.00221	CcSEcCtD
Etomidate—Vomiting—Terazosin—hypertension	0.000106	0.00218	CcSEcCtD
Etomidate—Pain—Doxazosin—hypertension	0.000106	0.00218	CcSEcCtD
Etomidate—Pain—Fosinopril—hypertension	0.000104	0.00215	CcSEcCtD
Etomidate—Hypotension—Valsartan—hypertension	0.000104	0.00215	CcSEcCtD
Etomidate—Tachycardia—Clonidine—hypertension	0.000104	0.00214	CcSEcCtD
Etomidate—Hypotension—Olmesartan—hypertension	0.000104	0.00214	CcSEcCtD
Etomidate—Pain—Eplerenone—hypertension	0.000104	0.00214	CcSEcCtD
Etomidate—Vomiting—Acebutolol—hypertension	0.000103	0.00213	CcSEcCtD
Etomidate—Pain—Nifedipine—hypertension	0.000103	0.00213	CcSEcCtD
Etomidate—Pain—Verapamil—hypertension	0.000103	0.00212	CcSEcCtD
Etomidate—CYP19A1—central nervous system—hypertension	0.000102	0.00187	CbGeAlD
Etomidate—Vomiting—Labetalol—hypertension	0.000102	0.00211	CcSEcCtD
Etomidate—Hypertension—Perindopril—hypertension	0.000102	0.0021	CcSEcCtD
Etomidate—Hypertension—Irbesartan—hypertension	0.000102	0.00209	CcSEcCtD
Etomidate—Tachycardia—Trandolapril—hypertension	0.000101	0.00209	CcSEcCtD
Etomidate—Tachycardia—Enalapril—hypertension	0.000101	0.00208	CcSEcCtD
Etomidate—Bradycardia—Lisinopril—hypertension	0.000101	0.00208	CcSEcCtD
Etomidate—Tachycardia—Telmisartan—hypertension	9.96e-05	0.00205	CcSEcCtD
Etomidate—Hypotension—Clonidine—hypertension	9.95e-05	0.00205	CcSEcCtD
Etomidate—Vomiting—Eprosartan—hypertension	9.9e-05	0.00204	CcSEcCtD
Etomidate—Arrhythmia—Ramipril—hypertension	9.75e-05	0.00201	CcSEcCtD
Etomidate—Hypotension—Trandolapril—hypertension	9.71e-05	0.002	CcSEcCtD
Etomidate—Tachycardia—Captopril—hypertension	9.69e-05	0.002	CcSEcCtD
Etomidate—Hypotension—Enalapril—hypertension	9.67e-05	0.00199	CcSEcCtD
Etomidate—Vomiting—Amlodipine—hypertension	9.61e-05	0.00198	CcSEcCtD
Etomidate—Hypotension—Telmisartan—hypertension	9.54e-05	0.00197	CcSEcCtD
Etomidate—Arrhythmia—Timolol—hypertension	9.53e-05	0.00196	CcSEcCtD
Etomidate—Pain—Olmesartan—hypertension	9.51e-05	0.00196	CcSEcCtD
Etomidate—Ephedrine—ADRB2—hypertension	9.41e-05	0.0397	CrCbGaD
Etomidate—Tachycardia—Perindopril—hypertension	9.41e-05	0.00194	CcSEcCtD
Etomidate—Tachycardia—Irbesartan—hypertension	9.37e-05	0.00193	CcSEcCtD
Etomidate—Tachycardia—Hydrochlorothiazide—hypertension	9.3e-05	0.00192	CcSEcCtD
Etomidate—Hypotension—Captopril—hypertension	9.27e-05	0.00191	CcSEcCtD
Etomidate—Fenoprofen—PTGS1—hypertension	9.18e-05	0.0387	CrCbGaD
Etomidate—Pain—Clonidine—hypertension	9.11e-05	0.00188	CcSEcCtD
Etomidate—Tachycardia—Betaxolol—hypertension	9.05e-05	0.00187	CcSEcCtD
Etomidate—Vomiting—Metoprolol—hypertension	9.04e-05	0.00186	CcSEcCtD
Etomidate—Vomiting—Guanabenz—hypertension	9.04e-05	0.00186	CcSEcCtD
Etomidate—Hypotension—Perindopril—hypertension	9.01e-05	0.00186	CcSEcCtD
Etomidate—Hypotension—Irbesartan—hypertension	8.98e-05	0.00185	CcSEcCtD
Etomidate—Pethidine—SLC6A3—hypertension	8.97e-05	0.0378	CrCbGaD
Etomidate—Hypotension—Hydrochlorothiazide—hypertension	8.9e-05	0.00184	CcSEcCtD
Etomidate—Arrhythmia—Lisinopril—hypertension	8.84e-05	0.00182	CcSEcCtD
Etomidate—Tachycardia—Losartan—hypertension	8.82e-05	0.00182	CcSEcCtD
Etomidate—Hypotension—Furosemide—hypertension	8.75e-05	0.0018	CcSEcCtD
Etomidate—Pain—Telmisartan—hypertension	8.73e-05	0.0018	CcSEcCtD
Etomidate—Hypotension—Betaxolol—hypertension	8.67e-05	0.00179	CcSEcCtD
Etomidate—Pseudoephedrine—SLC6A3—hypertension	8.66e-05	0.0365	CrCbGaD
Etomidate—Pseudoephedrine—ADRA2A—hypertension	8.49e-05	0.0358	CrCbGaD
Etomidate—Pseudoephedrine—ADRB1—hypertension	8.48e-05	0.0358	CrCbGaD
Etomidate—Hypotension—Losartan—hypertension	8.45e-05	0.00174	CcSEcCtD
Etomidate—Vomiting—Propranolol—hypertension	8.3e-05	0.00171	CcSEcCtD
Etomidate—Pain—Perindopril—hypertension	8.24e-05	0.0017	CcSEcCtD
Etomidate—Convulsion—Ramipril—hypertension	8.23e-05	0.0017	CcSEcCtD
Etomidate—Pain—Irbesartan—hypertension	8.21e-05	0.00169	CcSEcCtD
Etomidate—Pain—Hydrochlorothiazide—hypertension	8.15e-05	0.00168	CcSEcCtD
Etomidate—Pseudoephedrine—TNF—hypertension	8.05e-05	0.0339	CrCbGaD
Etomidate—Vomiting—Indapamide—hypertension	8.03e-05	0.00166	CcSEcCtD
Etomidate—Vomiting—Diltiazem—hypertension	8.03e-05	0.00166	CcSEcCtD
Etomidate—Hypertension—Timolol—hypertension	8.02e-05	0.00165	CcSEcCtD
Etomidate—Pain—Furosemide—hypertension	8.01e-05	0.00165	CcSEcCtD
Etomidate—Vomiting—Carvedilol—hypertension	7.95e-05	0.00164	CcSEcCtD
Etomidate—Pain—Betaxolol—hypertension	7.93e-05	0.00164	CcSEcCtD
Etomidate—Vomiting—Doxazosin—hypertension	7.87e-05	0.00162	CcSEcCtD
Etomidate—Vomiting—Fosinopril—hypertension	7.77e-05	0.0016	CcSEcCtD
Etomidate—Pain—Losartan—hypertension	7.73e-05	0.00159	CcSEcCtD
Etomidate—Vomiting—Eplerenone—hypertension	7.72e-05	0.00159	CcSEcCtD
Etomidate—Vomiting—Nifedipine—hypertension	7.67e-05	0.00158	CcSEcCtD
Etomidate—Vomiting—Verapamil—hypertension	7.63e-05	0.00157	CcSEcCtD
Etomidate—Tachycardia—Ramipril—hypertension	7.56e-05	0.00156	CcSEcCtD
Etomidate—Hypotension—Ramipril—hypertension	7.24e-05	0.00149	CcSEcCtD
Etomidate—Pseudoephedrine—ADRB2—hypertension	7.13e-05	0.0301	CrCbGaD
Etomidate—Vomiting—Valsartan—hypertension	7.11e-05	0.00147	CcSEcCtD
Etomidate—Hypotension—Timolol—hypertension	7.08e-05	0.00146	CcSEcCtD
Etomidate—Vomiting—Olmesartan—hypertension	7.07e-05	0.00146	CcSEcCtD
Etomidate—Tachycardia—Lisinopril—hypertension	6.86e-05	0.00141	CcSEcCtD
Etomidate—Vomiting—Clonidine—hypertension	6.77e-05	0.0014	CcSEcCtD
Etomidate—Pethidine—SLC6A4—hypertension	6.71e-05	0.0283	CrCbGaD
Etomidate—Vomiting—Trandolapril—hypertension	6.61e-05	0.00136	CcSEcCtD
Etomidate—Vomiting—Enalapril—hypertension	6.58e-05	0.00136	CcSEcCtD
Etomidate—Hypotension—Lisinopril—hypertension	6.57e-05	0.00135	CcSEcCtD
Etomidate—Vomiting—Telmisartan—hypertension	6.49e-05	0.00134	CcSEcCtD
Etomidate—Pain—Timolol—hypertension	6.48e-05	0.00134	CcSEcCtD
Etomidate—Pseudoephedrine—SLC6A4—hypertension	6.48e-05	0.0273	CrCbGaD
Etomidate—Vomiting—Captopril—hypertension	6.31e-05	0.0013	CcSEcCtD
Etomidate—Vomiting—Perindopril—hypertension	6.13e-05	0.00126	CcSEcCtD
Etomidate—Vomiting—Irbesartan—hypertension	6.11e-05	0.00126	CcSEcCtD
Etomidate—Vomiting—Hydrochlorothiazide—hypertension	6.06e-05	0.00125	CcSEcCtD
Etomidate—Pain—Lisinopril—hypertension	6.01e-05	0.00124	CcSEcCtD
Etomidate—Vomiting—Furosemide—hypertension	5.96e-05	0.00123	CcSEcCtD
Etomidate—Vomiting—Betaxolol—hypertension	5.9e-05	0.00122	CcSEcCtD
Etomidate—Vomiting—Losartan—hypertension	5.75e-05	0.00118	CcSEcCtD
Etomidate—Fenoprofen—PTGS2—hypertension	5.25e-05	0.0221	CrCbGaD
Etomidate—Vomiting—Ramipril—hypertension	4.93e-05	0.00102	CcSEcCtD
Etomidate—Vomiting—Timolol—hypertension	4.82e-05	0.000993	CcSEcCtD
Etomidate—Fenoprofen—ALB—hypertension	4.68e-05	0.0197	CrCbGaD
Etomidate—Vomiting—Lisinopril—hypertension	4.47e-05	0.000921	CcSEcCtD
Etomidate—Pethidine—ALB—hypertension	3.53e-05	0.0149	CrCbGaD
Etomidate—CYP11B1—Metabolism—CAV1—hypertension	2.86e-06	3.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SERPINE1—hypertension	2.86e-06	3.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CX3CL1—hypertension	2.86e-06	3.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BDKRB1—hypertension	2.86e-06	3.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HDAC6—hypertension	2.86e-06	3.46e-05	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—hypertension	2.85e-06	3.45e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOA1—hypertension	2.85e-06	3.45e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ALB—hypertension	2.85e-06	3.45e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCE—hypertension	2.84e-06	3.44e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDN1—hypertension	2.83e-06	3.43e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CTGF—hypertension	2.81e-06	3.41e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCL5—hypertension	2.81e-06	3.4e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—VAV3—hypertension	2.8e-06	3.39e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HSPG2—hypertension	2.8e-06	3.39e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMGCR—hypertension	2.79e-06	3.38e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GOT2—hypertension	2.79e-06	3.38e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GABBR1—hypertension	2.78e-06	3.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADM—hypertension	2.78e-06	3.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDE4D—hypertension	2.78e-06	3.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTH—hypertension	2.78e-06	3.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKG1—hypertension	2.78e-06	3.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RHOA—hypertension	2.76e-06	3.34e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	2.75e-06	3.33e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNB3—hypertension	2.74e-06	3.32e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ADRA2A—hypertension	2.73e-06	3.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS3—hypertension	2.73e-06	3.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3R1—hypertension	2.73e-06	3.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GLP1R—hypertension	2.71e-06	3.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TACR1—hypertension	2.71e-06	3.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CYBB—hypertension	2.71e-06	3.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL8—hypertension	2.71e-06	3.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AVP—hypertension	2.7e-06	3.27e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADCY5—hypertension	2.69e-06	3.25e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCG—hypertension	2.67e-06	3.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNAS—hypertension	2.67e-06	3.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRH3—hypertension	2.66e-06	3.22e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCA—hypertension	2.65e-06	3.21e-05	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—hypertension	2.63e-06	3.19e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALB—hypertension	2.62e-06	3.17e-05	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ALB—hypertension	2.58e-06	3.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDN1—hypertension	2.57e-06	3.11e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TH—hypertension	2.55e-06	3.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL5—hypertension	2.55e-06	3.09e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CALM2—hypertension	2.55e-06	3.08e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR5—hypertension	2.53e-06	3.06e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCD—hypertension	2.53e-06	3.06e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—hypertension	2.52e-06	3.05e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—hypertension	2.51e-06	3.04e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3R1—hypertension	2.51e-06	3.04e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NOS3—hypertension	2.51e-06	3.04e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GCG—hypertension	2.49e-06	3.01e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC2A4—hypertension	2.49e-06	3.01e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—POMC—hypertension	2.48e-06	3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCF2—hypertension	2.48e-06	3e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2A—hypertension	2.47e-06	3e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—C3—hypertension	2.47e-06	2.99e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—INS—hypertension	2.46e-06	2.98e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADCY5—hypertension	2.44e-06	2.95e-05	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—hypertension	2.43e-06	2.95e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCG—hypertension	2.42e-06	2.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NPY—hypertension	2.41e-06	2.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VWF—hypertension	2.41e-06	2.92e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GOT1—hypertension	2.41e-06	2.91e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCA—hypertension	2.41e-06	2.91e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AGT—hypertension	2.35e-06	2.84e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—STK11—hypertension	2.34e-06	2.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL2—hypertension	2.33e-06	2.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1B—hypertension	2.33e-06	2.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OXT—hypertension	2.33e-06	2.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AGTR2—hypertension	2.33e-06	2.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFBR1—hypertension	2.3e-06	2.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—F2R—hypertension	2.3e-06	2.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCD—hypertension	2.3e-06	2.78e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR5—hypertension	2.3e-06	2.78e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—hypertension	2.29e-06	2.78e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALB—hypertension	2.26e-06	2.74e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2A—hypertension	2.25e-06	2.72e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—C3—hypertension	2.24e-06	2.72e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCF1—hypertension	2.23e-06	2.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDNRB—hypertension	2.23e-06	2.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TAC1—hypertension	2.21e-06	2.67e-05	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—hypertension	2.2e-06	2.67e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hypertension	2.19e-06	2.66e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—COMT—hypertension	2.17e-06	2.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—F2—hypertension	2.17e-06	2.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCB—hypertension	2.17e-06	2.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ANXA1—hypertension	2.16e-06	2.62e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCR3—hypertension	2.16e-06	2.62e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NOS3—hypertension	2.16e-06	2.62e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3R1—hypertension	2.16e-06	2.62e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IKBKB—hypertension	2.14e-06	2.6e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNB3—hypertension	2.14e-06	2.59e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARGC1A—hypertension	2.14e-06	2.59e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMOX1—hypertension	2.13e-06	2.58e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AGT—hypertension	2.13e-06	2.58e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDNRA—hypertension	2.1e-06	2.55e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SST—hypertension	2.1e-06	2.55e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAT—hypertension	2.1e-06	2.55e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CALM1—hypertension	2.1e-06	2.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CYBA—hypertension	2.1e-06	2.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD3—hypertension	2.1e-06	2.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRB1—hypertension	2.1e-06	2.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FLT1—hypertension	2.1e-06	2.54e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hypertension	2.09e-06	2.53e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNAS—hypertension	2.09e-06	2.53e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EP300—hypertension	2.07e-06	2.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRA2A—hypertension	2.06e-06	2.49e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GHRL—hypertension	2.05e-06	2.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLAT—hypertension	2.05e-06	2.48e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOB—hypertension	2.04e-06	2.47e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CALCA—hypertension	2.03e-06	2.45e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SRC—hypertension	2.02e-06	2.44e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTEN—hypertension	2e-06	2.42e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—hypertension	1.99e-06	2.41e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BDKRB2—hypertension	1.98e-06	2.4e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—hypertension	1.98e-06	2.39e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—POMC—hypertension	1.98e-06	2.39e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—F2—hypertension	1.97e-06	2.39e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCB—hypertension	1.97e-06	2.39e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—hypertension	1.96e-06	2.38e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRBK1—hypertension	1.96e-06	2.37e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LPL—hypertension	1.95e-06	2.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CNR1—hypertension	1.94e-06	2.35e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CALM2—hypertension	1.92e-06	2.33e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ADCY5—hypertension	1.91e-06	2.31e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—EP300—hypertension	1.91e-06	2.31e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GPX1—hypertension	1.9e-06	2.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT2—hypertension	1.9e-06	2.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD2—hypertension	1.9e-06	2.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR7—hypertension	1.9e-06	2.3e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PRKCA—hypertension	1.88e-06	2.28e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1A1—hypertension	1.88e-06	2.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GCG—hypertension	1.88e-06	2.27e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTPN1—hypertension	1.88e-06	2.27e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CD36—hypertension	1.85e-06	2.24e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH2—hypertension	1.84e-06	2.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KL—hypertension	1.84e-06	2.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ITGAV—hypertension	1.81e-06	2.19e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGFR—hypertension	1.81e-06	2.19e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB1—hypertension	1.8e-06	2.18e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KNG1—hypertension	1.8e-06	2.18e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—POMC—hypertension	1.79e-06	2.17e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRL—hypertension	1.79e-06	2.17e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AGTR1—hypertension	1.79e-06	2.17e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HDAC1—hypertension	1.76e-06	2.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STK11—hypertension	1.76e-06	2.14e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—hypertension	1.76e-06	2.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL2—hypertension	1.76e-06	2.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL10—hypertension	1.75e-06	2.12e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLG—hypertension	1.74e-06	2.11e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—RHOA—hypertension	1.74e-06	2.11e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT2—hypertension	1.72e-06	2.09e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTEN—hypertension	1.72e-06	2.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3R1—hypertension	1.72e-06	2.09e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARA—hypertension	1.72e-06	2.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRB2—hypertension	1.7e-06	2.06e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCE—hypertension	1.68e-06	2.03e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AGT—hypertension	1.67e-06	2.02e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDGFA—hypertension	1.66e-06	2.01e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VAV3—hypertension	1.66e-06	2.01e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—EP300—hypertension	1.64e-06	1.99e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CALM1—hypertension	1.64e-06	1.99e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—hypertension	1.63e-06	1.98e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFBR2—hypertension	1.63e-06	1.98e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAV1—hypertension	1.62e-06	1.96e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNB3—hypertension	1.62e-06	1.96e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOA1—hypertension	1.62e-06	1.96e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AVP—hypertension	1.6e-06	1.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—RHOA—hypertension	1.58e-06	1.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNAS—hypertension	1.57e-06	1.91e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3R1—hypertension	1.57e-06	1.9e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOB—hypertension	1.54e-06	1.87e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTK2—hypertension	1.54e-06	1.86e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL8—hypertension	1.53e-06	1.85e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDN1—hypertension	1.52e-06	1.84e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL5—hypertension	1.51e-06	1.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—hypertension	1.48e-06	1.8e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LPL—hypertension	1.47e-06	1.78e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—H2AFX—hypertension	1.46e-06	1.77e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDGFRB—hypertension	1.46e-06	1.77e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RPS6KB1—hypertension	1.46e-06	1.77e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADCY5—hypertension	1.44e-06	1.75e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCG—hypertension	1.43e-06	1.73e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—hypertension	1.42e-06	1.72e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ITGB3—hypertension	1.42e-06	1.72e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCA—hypertension	1.42e-06	1.72e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—YWHAZ—hypertension	1.41e-06	1.71e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—POMC—hypertension	1.4e-06	1.7e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—INS—hypertension	1.4e-06	1.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGF—hypertension	1.39e-06	1.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SPP1—hypertension	1.39e-06	1.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL8—hypertension	1.39e-06	1.68e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR5—hypertension	1.36e-06	1.64e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCD—hypertension	1.36e-06	1.64e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2A—hypertension	1.33e-06	1.61e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—C3—hypertension	1.33e-06	1.61e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDGFB—hypertension	1.29e-06	1.56e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGFR1—hypertension	1.28e-06	1.55e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALB—hypertension	1.28e-06	1.55e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HIF1A—hypertension	1.26e-06	1.53e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AGT—hypertension	1.26e-06	1.53e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—hypertension	1.25e-06	1.52e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CALM1—hypertension	1.24e-06	1.5e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LEP—hypertension	1.23e-06	1.49e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—hypertension	1.23e-06	1.49e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3R1—hypertension	1.22e-06	1.48e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NOS3—hypertension	1.22e-06	1.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CAV1—hypertension	1.22e-06	1.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOA1—hypertension	1.22e-06	1.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KDR—hypertension	1.21e-06	1.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCB—hypertension	1.16e-06	1.41e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FN1—hypertension	1.16e-06	1.41e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—F2—hypertension	1.16e-06	1.41e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—hypertension	1.15e-06	1.4e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH1—hypertension	1.14e-06	1.38e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—hypertension	1.12e-06	1.36e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—POMC—hypertension	1.06e-06	1.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INS—hypertension	1.05e-06	1.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL2—hypertension	1.04e-06	1.26e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—hypertension	1.02e-06	1.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT2—hypertension	1.02e-06	1.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—hypertension	1.01e-06	1.23e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—hypertension	9.93e-07	1.2e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTEN—hypertension	9.77e-07	1.18e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SERPINE1—hypertension	9.68e-07	1.17e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGF2—hypertension	9.37e-07	1.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RHOA—hypertension	9.34e-07	1.13e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—EP300—hypertension	9.32e-07	1.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3R1—hypertension	9.25e-07	1.12e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOS3—hypertension	9.25e-07	1.12e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RELA—hypertension	8.7e-07	1.05e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MTOR—hypertension	8.53e-07	1.03e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL8—hypertension	8.2e-07	9.93e-06	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—hypertension	7.92e-07	9.59e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—hypertension	7.8e-07	9.44e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—hypertension	7.42e-07	8.98e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1A—hypertension	7.39e-07	8.95e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTEN—hypertension	7.37e-07	8.93e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK8—hypertension	7.21e-07	8.74e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—hypertension	7.19e-07	8.71e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EP300—hypertension	7.03e-07	8.52e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SRC—hypertension	6.84e-07	8.28e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—hypertension	6.66e-07	8.07e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—hypertension	6.13e-07	7.42e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—hypertension	6.11e-07	7.4e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—hypertension	5.99e-07	7.26e-06	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—hypertension	5.63e-07	6.82e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—hypertension	5.03e-07	6.09e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—hypertension	4.61e-07	5.58e-06	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—hypertension	4.25e-07	5.15e-06	CbGpPWpGaD
